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Phenotypic and genotypic characterization 
of biofilm producing clinical coagulase negative 
staphylococci from Nepal and their antibiotic 
susceptibility pattern
Sarita Manandhar1,2*, Anjana Singh3, Ajit Varma2, Shanti Pandey4 and Neeraj Shrivastava2* 
Abstract 
Background: Coagulase-negative staphylococci (CNS) survive as commensals of skin, anterior nares and external 
canals of human and were regarded as non-infectious pathogens. However, they are emerging as a major cause of 
nosocomial infectious due to their ability to form biofilms and high resistance to several classes of antibiotics. This 
study examines the biofilm forming abilities of 214 clinical CNS isolates using phenotypic and genotypic methods, 
and determines their antibiotic susceptibility patterns.
Methods: A total of 214 clinical isolates collected from different clinical samples were identified as CNS and their 
antibiotic susceptibility determined by CLSI guidelines. The biofilm forming ability of all isolates was determined by 
three phenotypic methods; Congo red agar (CRA) method, tube adherence method (TM) and tissue culture plate 
(TCP) method and by genotypic method for the detection of icaAD genes.
Results: Among all the isolates, S. epidermidis (57.5%) was found the most frequently, followed by S. saprophyticus 
(18.7%), S. haemolyticus (11.2%), S. hominis (7%), and S. capitis (5.6%). Antibiotic susceptibility pattern demonstrated 
91.6% isolates were resistant to penicillin and 66.8% to cefoxitin while 91.1% isolates were susceptible to chloram-
phenicol. Constitutive and inducible clindamycin resistant phenotype as measured by D-test was seen among 28% 
and 14.5% of isolates respectively. Tissue culture plate method detected biofilm production in 42.1% isolate followed 
by 31.8% through tube method while 20.1% isolates were found to produce slime in Congo red agar method. The 
genotypic assay revealed presence of icaA and icaD genes in 19.2% isolates.
Conclusion: The study shows a high prevalence of biofilm formation and inducible clindamycin resistance in CNS 
isolates, indicating the importance of in-vitro biofilm production test and D-test in routine laboratory diagnostics. 
Implementation of efficient diagnostic techniques for detection of biofilm production in clinical samples can help 
manage staphylococcal infections and minimize risks of treatment failures in hospitals.
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Background
Presently, the wide-spread use of implants in modern 
healthcare facilities has substantially increased the risk of 
device associated infections, which in turn has drastically 
increased the rate of mortality and morbidity. Non-path-
ogenic indigenous microbiota of skin, nares and other 
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mucosal surfaces of human, coagulase-negative staphy-
lococci (CNS) are opportunistic pathogens accounting 
as one of the most common etiologic agents of device 
related infections [1, 2]. Over the past few decades, CNS, 
especially Staphylococcus epidermidis has emerged as a 
major cause of nosocomial infections [3–5]. The patho-
gen, now regarded as a life threatening, causes septice-
mia, meningitis, endocarditis and other serious invasive 
infections. Immunocompromised individuals or patients 
undergoing treatment with indwelling devices such as 
catheters and tips are more vulnerable to contract the 
CNS infections. Therefore, paradoxically, medical devices 
aimed to improve the treatment outcome, have often 
contributed to the prevalence of nosocomial infections 
[1, 5, 6], increasing the clinical significance of CNS.
Biofilm production is one of the major arsenals of sap-
rophytic microbiota to become an opportunistic patho-
gen [7, 8]. Through biofilms, the CNS can adhere to and 
colonize on biotic as well as abiotic surfaces. Likewise, 
the damaged host tissue caused by prolonged antibiotic 
use and the implanted devices facilitate the survival, pro-
liferation, and virulence of these pathogens [4, 6]. The 
biofilm of CNS is composed of the layer of extracellular 
polymeric substance called polysaccharide intercellular 
adhesion (PIA) matrix, which is encoded by ica operon 
(icaADBC genes) [9]. Beneath the biofilm matrix, bacte-
ria are protected from physical, chemical, and biological 
stresses imposed by the antibiotics and the host immune 
cells [4]. Indeed, increased evidences show that the bac-
teria embedded within biofilms are difficult to kill by 
the antibiotics that are effective against planktonic cells, 
leading to the treatment failures of biofilm infections [1, 
10, 11]. Moreover, the dispersal phenomenon of biofilms 
also serves as a source to metastatic infections [1, 4, 10]. 
There are mounting evidences of antibiotic resistance 
among biofilm forming clinical staphylococcal isolates. 
Furthermore, polymicrobial proximity within the biofilm 
might facilitate horizontal exchange of genetic informa-
tion leading to development of antibiotic resistant clonal 
population [7]. Therefore, considering the clinical sig-
nificance of biofilm associated infections, prevention and 
management of CNS infections remain a priority for the 
betterment of public health. This warrants the implemen-
tation of efficient methods to detect biofilm production 
among clinical samples in routine laboratory diagnosis.
The antimicrobial susceptibility testing (AST) of a clini-
cal isolate is crucial for the optimal antimicrobial treat-
ment of infected patients. This practice has been even 
more critical considering the single or multidrug resist-
ant microorganisms [12]. Studies have reported clinical 
antibiotic resistance including that against erythromy-
cin, macrolides, lincosamides and streptogramins type 
B  (MLSB) in clinical CNS isolates [13, 14]. Many studies 
have reported the prevalence of antibiotic resistance 
including  MLSB resistance S. aureus isolates from dif-
ferent regions of Nepal [15–22]. Recent studies although 
have reported antibiotic resistance and biofilm in clini-
cal CNS isolates [22, 23], the prevalence of  MLSB resist-
ance in the CNS isolates are lacking in Nepal. Herein, we 
report the prevalence of antibiotic resistance and biofilm 
production among clinical CNS isolates collected from 
two tertiary care hospitals of Nepal.
Methods
Isolation and identification of coagulase‑negative 
staphylococci (CNS)
A descriptive cross sectional study was carried out at two 
tertiary care hospitals of Nepal; B & B hospital and Kath-
mandu Institute of Technology (KIST) Medical College 
& Hospital. A total of 214 isolates were collected from 
various clinical samples including central venous catheter 
(CVC), catheter tip, suction tip, drain tip, Double J (DJ) 
stent, tracheal tip, endotracheal tip, blood, wound/pus 
and urine.
The elution of the bacterial cells from CVC or catheters 
was done by following standard microbiological proto-
col routinely followed in the hospital. The catheter tips 
were collected in sterile container and then mixed with 
2 ml of nutrient broth (NB). After mixing by vortexing, 
loop-full of the suspension was streaked on MacConkey 
Agar (MA), Blood Agar (BA) plate and further processed 
for bacterial identification. The isolates were identified as 
staphylococci according to the standard microbiological 
procedure which included colony morphology on BA and 
mannitol salt agar (MSA), Gram staining and biochemi-
cal tests including catalase, slide and tube coagulase tests 
and oxidative/fermentative (O/F) test [25]. Once the iso-
lates were identified as CNS, they were classified into 
species following simplified scheme proposed by Cunha 
et  al., [26] using several biochemical tests. After identi-
fication of species, the isolates were stored in tryptic soy 
broth (TSB) with glycerol in freezer at −20 °C for further 
use.
Phenotypic and genotypic characterization of biofilm 
formation
Both phenotypic and genotypic methods were used for 
the detection of biofilm production in all the isolates. 
ATCC 35983 S. epidermidis strain was used as positive 
control for biofilm production in all assays performed.
Congo red agar method (CRA)
The screening of biofilm production was performed 
using CRA media; a qualitative method as described by 
Freeman et  al., [27]. The medium composed of Brain 
Heart Infusion (BHI) agar supplemented with sucrose 
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and a dye; Congo red. These plates were inoculated with 
CNS isolates, incubated aerobically at 37 ºC for 24 h and 
were interpreted based on the qualitative observation of 
colored colonies formation on the CRA plates. The black 
colonies with dark consistency were regarded as strong 
biofilm producers while the pink colonies were regarded 
as biofilm non-producers. The experiments were per-
formed in triplicates and repeated three times.
Tube adherence method (TM)
This qualitative method for the detection of biofilm for-
mation was performed as described by Christensen et al. 
[28]. A loop-full of microorganism was inoculated in 
trypticase soy broth (TSB) supplemented with 1% glu-
cose. The tubes were incubated at 37  ºC for 24  h. The 
tubes were decanted, washed with PBS (pH 7.3) for 4 
times and dried. Tubes were then stained with 0.1% crys-
tal violet for 15 min. Excess stain was removed by wash-
ing with deionized water for 3 times. The tubes were then 
dried in inverted position and observed for biofilm for-
mation. In this assay, biofilm formation was considered 
positive when a visible film was observed along the inner 
wall and bottom of tube. Depending on this, isolates were 
scored as 0 for absence, + for weak, +  + for moderate, 
and +  +  + for strong biofilm formation. The experiments 
were performed in triplicates and repeated three times.
Tissue culture plate (TCP) method
All the isolates were screened for their ability to pro-
duce biofilm by this quantitative method as previously 
described by Christensen et al. [28] with slight modifica-
tion [22]. In this assay, a loop-full of organism was inoc-
ulated in 5 mL TSB supplemented with 1% glucose and 
incubated at 37º C for 24  h. The overnight culture was 
diluted 1:100 with fresh media and 0.2 mL of this diluted 
culture was inoculated into individual wells of sterile 
polystyrene 96 well flat bottom tissue culture plates and 
incubated at 37 ºC for 24 h. After incubation, the content 
of tissue culture plate was removed by gentle tapping, and 
washed with PBS (pH 7.2) 4 times to remove free flowing 
planktonic bacteria. Biofilms formed by adherent sessile 
bacteria in the plate were fixed with 2% sodium acetate. 
It was then stained with 0.1% crystal violet for 15 min at 
room temperature. Excess stain was rinsed off by washing 
with deionized water for 4 times and plates were dried. 
Optical density (OD) of stained adherent bacteria was 
measured with micro ELISA auto reader at OD  630  nm. 
OD values from sterile medium, fixative and dye were 
averaged and subtracted from all test values. The experi-
ments were performed in triplicates and repeated three 
times. Bacterial adherence was classified based on OD 
values of the individual isolates. Mean OD value < 0.120, 
0.120–0.240 and > 0.240 were classified as non/weak, 
moderate and strong biofilm adherence respectively.
Detection of ica genes
The genomic DNA was extracted as previously described 
[22] using the DNA extraction Kit (Thermo Fischer). The 
sequences of icaA and icaD (accession number U43366) 
were taken from the GenBank sequence of the National 
Center for Biotechnology Information (NCBI) database. 
Primers specific for icaA and icaD were forward 5′-TCT 
CTT GCA GGA GCA ATC AA, reverse 5′-TCA GGC ACT 
AAC ATC CAG CA generating a product size of 188  bp 
and forward 5′-ATG GTC AAG CCC AGA CAG AG, 
reverse 5′-CGT GTT TTC AAC ATT TAA TGCAA with a 
product size of 198 bp respectively [22]. A 25 μl of reac-
tion mixture consisted of  MgCl2 (2.5 mM), Taq DNA pol-
ymerase (1U), each dNTPs (100 μM), each primer (1 μM) 
and DNA extract (200  ng). DNA amplification was car-
ried out with following parameters: preheating at 95  °C 
for 5  min followed by 35 cycles of amplification (dena-
turation at 94 °C for 30 s, annealing at 55 °C for 30 s and 
elongation at 72 °C for 30 s) and termination at 72 °C for 
2 min. The PCR product was analyzed in 2% agarose gel 
stained with SYBR safe dye (Invitrogen).
Antimicrobial susceptibility testing (AST)
AST of the isolates was performed on Mueller Hinton 
Agar (MHA) by modified Kirby-Bauer disk diffusion 
method recommended by clinical laboratory standard 
institution (CLSI) guidelines [29]. The antimicrobial discs 
(HiMedia Laboratories) used in the study were: penicil-
lin (10 units), ciprofloxacin (30  µg/disc), tetracycline 
(30  µg/disc), clindamycin (2  µg/disc), chloramphenicol 
(30 µg/disc), cefoxitin (30 µg/disc), erythromycin (15 µg/
disc), cotrimoxazole (1.25/23.75 µg/disc) and gentamicin 
(10 µg/disc). The cefoxitin disc was used to detect methi-
cillin resistance. The Staphylococcus aureus ATCC 25923 
was used as reference strain for analyzing AST results.
Screening of inducible clindamycin resistance
The double disc diffusion test or D zone test outlined in 
CLSI document M100-S25 [29] was performed to deter-
mine if the erythromycin resistant isolates expressed 
inducible clindamycin resistance. Erythromycin (15 µg) 
disc was placed at a distance of 15 mm (edge to edge) 
from clindamycin (2 µg) on Mueller Hinton agar plates 
previously inoculated with 0.5 McFarland bacterial sus-
pensions. Plates were analyzed after 18 h of incubation 
at 37 °C. Interpretation of the inhibition zone diameters 
was as follows: If an isolate was erythromycin resistant 
and clindamycin susceptible, with a D-shaped inhibi-
tion zone around the clindamycin disc, it was consid-
ered positive for inducible resistance (D-test positive, 
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 iMLSB phenotype). If the isolate was erythromycin 
resistant and clindamycin susceptible, with both zones 
of inhibition showing a circular shape, the isolate was 
considered to be negative for inducible resistance (D 
test negative, MS phenotype), but to have an active 
efflux pump. If the isolate was resistant to both drugs, 
it was considered to have the macrolide–lincosamide–
Streptogramin B constitutive  (cMLSB phenotype) [30].
Statistical analysis
The statistical analysis was performed using SPSS 
17.0 (SPSS Inc., Chicago, USA) software. Chi-square 
test was used to compare between groups and P val-
ues < 0.05 were considered statistically significant.
Results
Isolation and identification of CNS
A total of 214 isolates were identified as CNS from vari-
ous clinical samples following standard microbiological 
procedure using different biochemical tests [25]. Five 
species were identified among all CNS isolates includ-
ing S. epidermidis (57.5%); the most frequently isolated 
species followed by S. saprophyticus (18.7%), S. haemo-
lyticus (11.2%), S. homonis (7%) and S. captis (5.6%) 
(Fig. 1).
Frequency of CNS isolated from different clinical 
specimens
S. epidermidis was isolated from all specimen types 
received in the laboratory. It was most frequently iso-
lated from blood (52, 42.3%) followed by wound/pus 
(34, 27.6%). Similarly, S. saprophyticus was also mostly 
isolated from blood (12, 30%) and wound/pus (12, 30%). 
Different implant devices were also found to harbor CNS. 
All CNS were isolated from catheter tip except S. homi-
nis. However, S. hominis were isolated from CVC, blood, 
wound/pus and urine. On the other hand, S. saprophyti-
cus and S. haemolyticus were not isolated from suction 
tip, drain tip, tracheal tip and endotracheal tip. Similarly, 
S. capitis were isolated only from CVC, catheter tip, 
blood, and wound/pus (Table 1). 
Antibiotic susceptibility pattern among CNS isolates
Antibiotic susceptibility testing of 9 clinically relevant 
antibiotics was performed against all the collected iso-
lates. These antibiotics were selected because of their 
common use in clinical practice in hospitals of Nepal. 
Among all CNS, 91.6% isolates were found to be resist-
ant to penicillin. Mostly, S. epidermidis (114, 92.7%), S. 
saprophyticus (35, 87.5%) and S. haemolyticus (23, 95.8%) 
were susceptible to chloramphenicol. Similarly, S. capitis 
(12, 100%) and S. hominis (14, 93.3%) were susceptible to 
tetracycline (Table  2). Cefoxitin disc was used to detect 
methicillin resistance, which was observed in 66.8% CNS 
isolates. All five CNS species were found to be methicil-
lin resistant with 73 (59.3%) S. epidermidis, 29 (72.5%) S. 
saprophyticus, 21 (87.5%) S. haemolyticus, 10 (66.7%) S. 
hominis and 10 (83.3%) S. capitis (Table 2).
Inducible clindamycin resistance
Clindamycin is a useful drug in the treatment of serious 
infections caused by Staphylococci due to its excellent 
tissue penetration, good oral absorption, and is an alter-
native to penicillin allergic patients. However, it has been 
indicated that approximately 45% of erythromycin resist-
ant S. aureus isolates have inducible  MLSB resistance that Fig. 1 Percentage of CNS isolated from various clinical samples
Table 1 Frequency of CNS isolated from different clinical specimens
CVC central venous catheter; others (Suction tip, Drain tip, Double J stent, Tracheal tip, Endotracheal tube)
CNS Clinical specimen Total
CVC Catheter tip Blood Wound/pus Urine Others
S. epidermidis 8 (6.5%) 14 (11.4%) 52 (42.3%) 34 (27.6%) 11(8.9%) 4 (3.3%) 123 (57.5%)
S. saprophyticus 2 (5.0%) 2 (5.0%) 12 (30.0%) 12 (30.0%) 11(27.5%) 1(2.5%) 40 (18.7%)
S. hemolyticus 6 (25.0%) 6 (25.0%) 5 (20.8%) 5 (20.8%) 1(4.2%) 1(4.2%) 24 (11.2%)
S. hominis 1 (6.7%) – 10 (66.7%) 3 (20.0%) 1 (6.7%) – 15 (7.0%)
S. capitis 3 (25.0%) 3 (25.0%) 3 (25.0%) 2 (16.7%) – 1(8.3%) 12 (5.6%)
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would go unrecognized if erythromycin and clindamycin 
disc are not placed appropriately during routine antibi-
otic susceptibility test [29, 31]. Among 214 CNS, 155 
(72.4%) were resistant to erythromycin. MS phenotype 
(D test) was performed for these isolates and showed 
that 60 (28%) isolates were resistant to both erythromy-
cin and clindamycin indicating constitutive  MLSB pheno-
type. Out of 151 clindamycin sensitive isolates, positive 
D test was observed among 31(14.5%) isolates, indicating 
inducible  MLSB phenotype. Negative D-test results were 
obtained among 70 (32.7%) isolates, whereas, the remain-
ing 53 (24.8%) isolates were susceptible to both eryth-
romycin and clindamycin. Constitutive and inducible 
 MLSB phenotype was 51 (23.8%) and 25 (11.7%) among 
methicillin resistant CNS and 9 (4.2%) and 6 (2.8%) in 
methicillin sensitive CNS respectively. Both constitutive 
and inducible  MLSB phenotype was predominant among 
MRCNS as compared to MSCNS (Table 3).
Biofilm formation among CNS isolates
Biofilm production was assessed by both phenotypic and 
genotypic methods. The slime production ability of iden-
tified clinical CNS isolates was screened by CRA method. 
Among 214 CNS, 20 (9.3%) isolates produced black colo-
nies indicating strong positive for polysaccharide produc-
tion. The qualitative assessment of the amount of biofilm 
production was done by tube adherence method (TM) 
which showed strong production (+ + +) among 44 
(20.6%) isolates and moderate biofilm production among 
24 (11.2%) isolates. Biofilm production was determined 
quantitatively by tissue culture plate (TCP) method that 
demonstrated strong and moderate biofilm producers in 
35 (16.4%) and 55 (25.7%) CNS isolates. Among all CNS 
species, S. epidermidis was the most frequent species to 
produce biofilm in all phenotypic methods. In addition, 
genotypic assay also revealed this species harboring both 
icaA and icaD genes more frequently. The ica genes were 
detected in 41 (19.2%) of all CNS isolates. Among all 
methods, TCP detected biofilm production in a greater 
number of isolates in all species (Table 4).
Determination of biofilm formation among methicillin 
resistant CNS isolates
The biofilm production as detected by different pheno-
typic methods were higher in methicillin resistant than 
methicillin sensitive isolates but was not found to be 
statistically significant. Similarly, the ica genes were also 
found in higher number among methicillin resistant CNS 
than methicillin sensitive CNS but it was not found to be 
statistically significant (Table 5).
The icaAD genes are present in all clinical sample type
The study revealed that 14 (17.07%) CNS isolates from 
blood samples (n = 82) and 14 (25%) from wound/pus 
samples (n = 56) harbored ica genes. Likewise, ica genes 
were also present in six (30%) biomaterial isolates col-
lected from CVC (n = 20), four (16%) from catheters 
(n = 23), and one each from DJ stenting (n = 2), ET tip 
(n = 1), and urine samples (n = 24) (Fig. 2). The identifica-
tion of icaAD genes was done by PCR of DNA extracted 
from the CNS isolates using the primer listed in method 
section (Fig. 3).
Antibiotic susceptibility pattern of isolates that harbor ica 
genes
The antibiotic susceptibility patterns of the isolates har-
boring ica genes were determined. The study showed no 
significant difference in antibiotic susceptibility between 
icaAD positive and icaAD negative isolates. Methicillin 
resistance was observed more among the isolates harbor-
ing ica genes than those lacking it. Altogether, the result 
shows that not only biofilm formation but other factors 
are responsible for antibiotic resistance among CNS 
(Table 6).
Discussion
The coagulase-negative staphylococci (CNS) including 
S. epidermidis are ubiquitous in nature; reside on the 
skin of healthy individuals as normal flora. In fact, due 
to this phenomenon, CNS has been emerged as com-
mon nosocomial pathogens. In addition, the ability to 
Table 3 Erythromycin and clindamycin susceptibility testing
MRCNS Methicillin resistant CNS, MSCNS Methicillin sensitive CNS, E Erythromycin, CD Clindamycin, R Resistant, S Sensitive, MLSB Macrolides, Lincosamides and 
Streptogramin B
Phenotypes MRCNS MSCNS Total
(n) % (n) % (n) %
E-S, CD-S 18 8.4 35 16.4 53 24.8
E-R, CD-R (constitutive  MLSB) 51 23.8 9 4.2 60 28
E-R, CD-S (inducible  MLSB, D-positive) 25 11.7 6 2.8 31 14.5
E-R, CD-S (MS, D-negative) 49 22.9 21 9.8 70 32.7
Total 143 66.8 71 33.2 214 100
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form biofilms on biotic as well as abiotic surfaces have 
made them successful human pathogens causing per-
sistent infections leading to serious health problems. 
Given that biofilm is an important virulence factor that 
is mostly associated with antibiotic resistance for these 
pathogens, early detection in clinical specimen would 
impose significant impact in management of staphy-
lococcal nosocomial infections. Taking this into con-
sideration, the study was carried out to investigate the 
prevalence of biofilm producing CNS and antibiotic 
Table 4 Determination of biofilm formation in CNS by genotypic and phenotypic methods
Biofilm CNS isolates Total (n = 214)
S. epidermidis S. saprophyticus S. haemolyticus S. hominis S. capitis
(n = 123) (n = 40) (n = 24) (n = 15) (n = 12)
Congo red agar (CRA)
 Strong 12 (9.8%) 2 (5.0%) 3 (12.5%) 3 (20.0%) - 20 (9.3%)
 Moderate 12 (9.8%) 2 (5.0%) 5 (20.8%) 2 (13.3%) 2 (16.7%) 23 (10.7%)
 Weak/none 99 (80.5%) 36 (90.0%) 16 (66.7%) 10 (66.7%) 10 (83.3%) 171 (79.9%)
Tube adherence method (TM)
 Strong 33 (26.8%) 4 (10.0%) 2 (8.33%) 3 (20.0%) 2 (16.7%) 44 (20.6%)
 Moderate 9 (7.3%) 6 (15.0%) 6 (25.0%) 3 (20.0%) - 24 (11.2%)
 Weak/none 81 (65.9%) 30 (75.0%) 16 (66.7%) 9 (60.0%) 10 (83.3%) 146 (68.2%)
Tissue culture plate (TCP)
 Strong 23 (18.7%) 8 (20.0%) 3 (12.5%) 1 (6.7%) - 35 (16.4%)
 Moderate 32 (26.0%) 9 (22.5%) 4 (16.7%) 7 (46.7%) 3 (25.0%) 55 (25.7%)
 Weak/none 68 (55.3%) 23 (57.5%) 17 (70.8%) 7 (46.7%) 9 (75.0%) 124 (57.9%)
ica gene
 Present 29 (23.6%) 5 (12.5%) 2 (8.33%) 3 (20.0%) 2 (16.7%) 41 (19.2%)
 Absent 94 (76.4%) 35 (87.5%) 22 (91.7%) 12 (80.0%) 10 (83.3%) 173 (80.8%)
Table 5 Biofilm formation in CNS in relation to methicillin 
susceptibility
MRCNS Methicillin resistant CNS, MSCNS Methicillin sensitive CNS
Biofilm MRCNS MSCNS p‑value
Congo red agar (CRA) 0.322
 Present 26 (18.2%) 17 (23.9%)
 Absent 117 (81.8%) 54 (76.1%)
Tube adherence method (TM) 0.447
 Present 43 (30.1%) 25 (35.2%)
 Absent 100 (69.9%) 46 (64.8%)
Tissue culture plate (TCP) 0.529
 Present 58 (40.6%) 32 (45.1%)
 Absent 85 (59.4%) 39 (54.9%)
ica genes 0.824
 Present 28 (19.6%) 13 (18.3%)




Fig. 3 Representative picture of PCR amplification of icaA (188 bp) 
and icaD (198 bp) genes in CNS isolates
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resistant strains in different clinical samples collected 
from two tertiary care hospitals of Nepal.
Among 214 CNS, S. epidermidis was the most com-
mon isolate accounting for more than half (57.4%) of 
total numbers (n = 123) followed by S. saprophyticus 
(n = 40, 18.6%), S. haemolyticus (n = 24, 11.2%), S. homi-
nis (n = 15, 7%) and S. capitis (n = 12, 5.6%) (Table  1). 
Previous studies have also reported S. epidermidis as the 
most common isolates among CNS [24, 32–34]. While S. 
epidermidis was isolated form all clinical samples, it was 
more commonly isolated from blood, wound/pus. S. sap-
rophyticus along with blood and wound/pus was also iso-
lated from urine. The high number of S. saprophyticus in 
urine is consistent with the previous studies [24, 35] may 
be due to its adhering capacity to wall of urinary tract. 
Importantly, all CNS species were isolated from different 
medical devices indicating their ability to cause device 
associated infections.
Antibiotic resistance is a major human health problem. 
The present result also demonstrated that majority of 
isolates were 91.6% and 72.4% resistant to penicillin and 
erythromycin respectively. However, the study also dem-
onstrated majority of isolates being susceptible to chlo-
ramphenicol (91.1%) and tetracycline (87.4%). Such high 
frequency of susceptibility pattern of chloramphenicol is 
consistent with the previous study by [24, 33, 36, 37], but 
their study showed lower susceptibility in case of eryth-
romycin and penicillin. Indeed, similar susceptibility pro-
file for all CNS strains was found as that of S. epidermidis 
strains. This indicates CNS are still susceptible to the first 
line drug and being cheap, these antibiotics could be used 
for the treatment of CNS infections caused by CNS in a 
resource limiting country like Nepal.
Among all CNS isolates, constitutive  MLSB were pre-
sent among 51 (23.8%) isolates and inducible  MLSB 
among 25 (11.7%) isolates. While similar frequency of 
inducible  MLSB was demonstrated by Perez et al., [38] as 
high as 50% CNS were found to be positive in study by 
Schreckenberger et  al., [14]. These results indicate that 
constitutive and inducible  MLSB resistance is depend-
ent on the hospitals and the geographical area. None-
theless, chances of inducible  MLSB can be reduced by 
implementing reliable diagnostics of  MLSB in the clinical 
samples.
Biofilm formation remains the most important mech-
anism of pathogenicity among staphylococci [10]. 
Although CRA and TM methods detected the biofilm 
production in a smaller number of isolates, TCP method 
was able to detect biofilm production in 90 (42.1%) iso-
lates. Similar frequency of biofilm production in clinical 
CNS isolates was reported previously [39–41]. However, 
the higher frequency (65.38%) of biofilm production was 
reported by Shrestha et  al., [23] in a study, conducted 
in tertiary care hospital of eastern Nepal as well as the 
study by Oliveira et  al., [42], who reported 75% of CNS 
producing biofilm. Likewise, PCR amplification in our 
study revealed only 41 (19.2%) isolates possessing both 
icaA and icaD genes. This rate is lower as compared to 
the previous studies [33, 40]. The possible reasons are 
the various factors such as environment, nutrition, sub-
inhibitory concentration of certain antibiotics, and stress 
(temperature, osmolarity) might play a significant role in 
biofilm formation resulting in varied frequency of biofilm 
producers among clinical isolates [43–47].
Among 41 icaAD positive isolates, only 7 (17%) showed 
the positive result in CRA method. This is in contrast to 
the previous studies by Zhou et al., [48] who reported all 
icaAD positive isolates also produced black colonies on 
CRA method. Similarly, good correspondence between 
possession of icaAD genes and CRA positivity was 
reported by de Silva et al., [2]. Our result shows that not 
all biofilm producers as per phenotypic assays possessed 
Table 6 Antibiotic susceptibility pattern of ica positive isolates
Antibiotics ica genes p-value
Present Absent
Susceptible Resistant Susceptible Resistant
Penicillin 4 (1.9%) 37 (17.3%) 14 (6.5%) 159 (74.3%) 0.119
Ciprofloxacin 28 (13.1%) 13 (6.1%) 110 (51.4%) 63 (29.4%) 0.334
Tetracycline 38 (17.8%) 3 (1.4%) 149 (69.6%) 24 (11.2%) 6.590
Clindamycin 32 (15.0%) 9 (4.2%) 119 (55.6%) 54 (25.2%) 3.332
Chloramphenicol 38 (17.8%) 3 (1.4%) 157 (73.4%) 16 (7.5%) 0.231
Cefoxitin 13 (6.1%) 28 (13.1%) 58 (27.1%) 115 (53.7%) 0.049
Erythromycin 15 (7.0%) 26 (12.1%) 44 (20.6%) 129 (60.3%) 2.256
Cotrimoxazole 29 (13.6%) 12 (5.6%) 105 (49.1%) 68 (31.8%) 1.460
Gentamicin 35 (16.4%) 6 (2.8%) 134 (62.6%) 39 (18.2%) 1.464
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ica genes. Several previous studies have reported this 
phenomenon [49–52]. We speculated that while most 
of the staphylococcal isolates which form biofilm are 
dependent on the icaAD genes, other factors such as 
teichoic acids also contribute to form biofilm [33]. It may 
also be possible that inactivation of ica operon occurs 
due to the insertion of the IS256 insertion sequence. 
Similarly, the ica-negative, non-slime-producing isolates 
likely represent strains with alternate means of adhesion, 
such as microbial surface components recognizing adhe-
sive matrix molecules (MSCRAMMs). These findings 
reinforce the opinion that several mechanisms besides 
slime production are responsible for bacterial adhesion 
and hence biofilm production [43].
Our study revealed ica genes were present mostly 
among blood and wound/pus samples (14 isolates each). 
Our results are consistent with the study previously per-
formed [40] where quarter of the isolates from blood 
cultures and catheter tips produced biofilm. However, 
in contrast, we detected lesser frequency of biofilm pro-
duction in the biomaterial sample like CVC, catheter, 
DJ stenting and ET tip. Interestingly, we did not observe 
significant difference of antibiotic resistance among bio-
film producers and non-producers. Similar results were 
also reported previously [53] with no difference in anti-
microbial resistance between biofilm-producing and 
non-producing S. epidermidis. Nonetheless, altogether, 
the percentage of biofilm production was higher among 
S. epidermidis than in other CNS isolates indicating that 
biofilm production is an important virulence factor for 
the pathogenicity of S. epidermidis. However, the results 
also support the idea that neither biofilm nor the icaAD 
genes could alone be used as biomarker of clinical signifi-
cance, as suggested previously [2].
Conclusion
This study identified S. epidermidis as the most frequent 
species (57.5%) with the highest rate of biofilm produc-
tion in all CNS examined. Among all phenotypic meth-
ods, TCP method detected biofilm production in higher 
percentage of CNS. We observed high prevalence of 
methicillin resistance as well as the presence of both 
constitutive and inducible  MLSB phenotype in these 
clinical CNS isolates. However, the result showed no sig-
nificant difference in the prevalence of antibiotic resist-
ance between biofilm producers and non-producers 
CNS.
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